NHERF1: Molecular brake on the PI3K pathway in breast cancer

Breast Cancer Research

Volumn 10, Issue 2, 2008, Pages

  Georgescu, Maria Magdalena ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PHOSPHOPROTEIN; PLATELET DERIVED GROWTH FACTOR RECEPTOR; SODIUM HYDROGEN EXCHANGER REGULATORY FACTOR; SODIUM PROTON EXCHANGE PROTEIN; SODIUM-HYDROGEN EXCHANGER REGULATORY FACTOR; TUMOR MARKER;

ANIMAL; BREAST TUMOR; ENZYMOLOGY; FEMALE; HUMAN; METABOLISM; NOTE; SIGNAL TRANSDUCTION;

1-PHOSPHATIDYLINOSITOL 3-KINASE; ANIMALS; BREAST NEOPLASMS; FEMALE; HUMANS; PHOSPHOPROTEINS; PTEN PHOSPHOHYDROLASE; RECEPTORS, PLATELET-DERIVED GROWTH FACTOR; SIGNAL TRANSDUCTION; SODIUM-HYDROGEN ANTIPORTER; TUMOR MARKERS, BIOLOGICAL;

EID: 48949119476     PISSN: 14655411     EISSN: 1465542X     Source Type: Journal    
DOI: 10.1186/bcr1992     Document Type: Editorial

References (15)

1. Pan Y, Weinman EJ, Dai J. Na+/H+exchanger regulatory factor 1 inhibits platelet-derived growth factor signaling in breast cancer cells. Breast Cancer Res 2008, 10:R5. 10.1186/bcr1846, 18190691.
2. Takahashi Y, Morales FC, Kreimann EL, Georgescu MM. PTEN tumor suppressor associates with NHERF proteins to attenuate PDGF receptor signaling. EMBO J 2006, 25:910-920. 1383560, 16456542, 10.1038/sj.emboj.7600979.
3. Modi S, Seidman AD, Dickler M, Moasser M, D'Andrea G, Moynahan ME, Menell J, Panageas KS, Tan LK, Norton L, Hudis CA. A phase II trial of imatinib mesylate monotherapy in patients with metastatic breast cancer. Breast Cancer Res Treat 2005, 90:157-163. 10.1007/s10549-004-3974-0, 15803362.
4. Dai JL, Wang L, Sahin AA, Broemeling LD, Schutte M, Pan Y. NHERF (Na+/H+ exchanger regulatory factor) gene mutations in human breast cancer. Oncogene 2004, 23:8681-8687. 10.1038/sj.onc.1207962, 15467753.
5. Saal LH, Holm K, Maurer M, Memeo L, Su T, Wang X, Yu JS, Malmström PO, Mansukhani M, Enoksson J, Hibshoosh H, Borg A, Parsons R. PIK3CA mutations correlate with hormone receptors, node metastasis, and ERBB2, and are mutually exclusive with PTEN loss in human breast carcinoma. Cancer Res 2005, 65:2554-2559. 10.1158/0008-5472-CAN-04-3913, 15805248.
6. Pan Y, Wang L, Dai JL. Suppression of breast cancer cell growth by Na+/H+ exchanger regulatory factor 1 (NHERF1). Breast Cancer Res 2006, 8:R63. 1797034, 17078868, 10.1186/bcr1616.
7. Cardone RA, Bellizzi A, Busco G, Weinman EJ, Dell'Aquila ME, Casavola V, Azzariti A, Mangia A, Paradiso A, Reshkin SJ. The NHERF1 PDZ2 domain regulates PKA-RhoA-p38-mediated NHE1 activation and invasion in breast tumor cells. Mol Biol Cell 2007, 18:1768-1780. 1855021, 17332506, 10.1091/mbc.E06-07-0617.
8. Song J, Bai J, Yang W, Gabrielson EW, Chan DW, Zhang Z. Expression and clinicopathological significance of oestrogen-responsive ezrin-radixin-moesin-binding phosphoprotein 50 in breast cancer. Histopathology 2007, 51:40-53. 10.1111/j.1365-2559.2007.02730.x, 17593079.
9. Ediger TR, Kraus WL, Weinman EJ, Katzenellenbogen BS. Estrogen receptor regulation of the Na+/H+ exchange regulatory factor. Endocrinology 1999, 140:2976-2982. 10.1210/en.140.7.2976, 10385389.
10. Stemmer-Rachamimov AO, Wiederhold T, Nielsen GP, James M, Pinney-Michalowski D, Roy JE, Cohen WA, Ramesh V, Louis DN. NHE-RF, a merlin-interacting protein, is primarily expressed in luminal epithelia, proliferative endometrium, and estrogen receptor-positive breast carcinomas. Am J Pathol 2001, 158:57-62. 1850244, 11141479.
11. Morales FC, Takahashi Y, Kreimann EL, Georgescu MM. Ezrin-radixin-moesin (ERM)-binding phosphoprotein 50 organizes ERM proteins at the apical membrane of polarized epithelia. Proc Natl Acad Sci USA 2004, 101:17705-17710. 539771, 15591354, 10.1073/pnas.0407974101.
12. Shenolikar S, Voltz JW, Minkoff CM, Wade JB, Weinman EJ. Targeted disruption of the mouse NHERF-1 gene promotes internalization of proximal tubule sodiumphosphate cotransporter type IIa and renal phosphate wasting. Proc Natl Acad Sci USA 2002, 99:11470-11475. 123280, 12169661, 10.1073/pnas.162232699.
13. Voltz JW, Brush M, Sikes S, Steplock D, Weinman EJ, Shenolikar S. Phosphorylation of PDZ1 domain attenuates NHERF-1 binding to cellular targets. J Biol Chem 2007, 282:33879-33887. 10.1074/jbc.M703481200, 17895247.
14. Mortier E, Wuytens G, Leenaerts I, Hannes F, Heung MY, Degeest G, David G, Zimmermann P. Nuclear speckles and nucleoli targeting by PIP2-PDZ domain interactions. EMBO J 2005, 24:2556-2565. 1176451, 15961997, 10.1038/sj.emboj.7600722.
15. Saotome I, Curto M, McClatchey AI. Ezrin is essential for epithelial organization and villus morphogenesis in the developing intestine. Dev Cell 2004, 6:855-864. 10.1016/j.devcel.2004.05.007, 15177033.